Vanguard Fiduciary Trust’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.56M Sell
200,365
-1,251
-0.6% -$45K ﹤0.01% 2041
2026
Q1
$7.13M Buy
+201,616
New +$8.2M ﹤0.01% 1896

Other funds holding CNMD

Vanguard Fiduciary Trust's CNMD Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its CONMED (CNMD) stake by 0.62% in Q2 2026, selling an estimated $45K and leaving 200,365 shares worth $6.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

Vanguard Fiduciary Trust first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.13M in Q1 2026. 244 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Vanguard Fiduciary Trust held 200,365 shares of CONMED worth $6.56M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 1,251 CONMED shares in Q2 2026, an estimated $45K.
  • CONMED made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2041 holding.
  • Vanguard Fiduciary Trust first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's CONMED position peaked at $7.13M in Q1 2026.
  • 244 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.